Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Context Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Context Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Stacey Jennifer Evans | Director | – | Jun 26, 2026 | 1 |
| Smith Karen L. | Director | – | Jun 26, 2026 | 1 |
| Walker Luke Nathaniel | Director | – | Jun 26, 2026 | 1 |
| Pasternak Andy | Director | – | Jun 26, 2026 | 1 |
| West Linda | Director | – | Jun 26, 2026 | 1 |
| Kantoff Philip W. | Director | – | Jun 26, 2026 | 1 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | 80,010 | Feb 23, 2026 | 1 |
| Lehr Martin A. | Chief Executive Officer | 920,190Indirect | Feb 23, 2026 | 1 |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | 29,000 | Feb 23, 2026 | 1 |
| Chagin Karen Deborah | Chief Medical Officer | – | Feb 23, 2026 | 1 |
| Dansky Ullmann Claudio | Chief Medical Officer | – | Feb 14, 2025 | 0 |
| Berman Richard J | Director | – | Jun 14, 2024 | 0 |
| Sahmoud Tarek | Chief Medical Officer | 10,000 | Aug 17, 2022 | 0 |
| Dick Evan G. | Other: Former Section 16 officer | 82,960 | Feb 17, 2022 | 0 |
| Rencher William F. | Other: Former Section 16 officer | – | Feb 17, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 (view filing) | Jun 9 | 1 day | Lehr Martin A.Chief Executive Officer | PPurchase | +100.0K | $0.70 | +$70.0K | +12.2%920.2K after | |
| Jun 10, 2025 (view filing) | Jun 6 | 4 days | Levit Alex C.Chief Legal Officer, Corp. Sec | PPurchase | +20.0K | $0.58 | +$11.6K | +222.2%29.0K after | |
| Jun 10, 2025 (view filing) | Jun 6 | 4 days | Minai-Azary Jennifer LynnChief Financial Officer | PPurchase | +40.0K | $0.64 | +$25.6K | +100.0%80.0K after | |
| Feb 21, 2023 (view filing) | Feb 21 | Same day | Lehr Martin A.Chief Executive Officer | PPurchase | +5.82K | $0.84 | +$4.89K | +3.8%159.7K after | |
| Feb 13, 2023 (view filing) | Feb 13 | Same day | Lehr Martin A.Chief Executive Officer | PPurchase | +5.61K | $0.87 | +$4.88K | +3.8%153.9K after | |
| Feb 6, 2023 (view filing) | Feb 6 | Same day | Lehr Martin A.Chief Executive Officer | PPurchase | +5.04K | $0.97 | +$4.89K | +3.5%148.3K after | |
| Jan 30, 2023 (view filing) | Jan 30 | Same day | Lehr Martin A.Chief Executive Officer | PPurchase | +7.03K | $0.70 | +$4.92K | +5.2%143.2K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Lehr Martin A.Chief Executive Officer | PPurchase | +6.84K | $0.72 | +$4.92K | +5.3%136.2K after | |
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Lehr Martin A.Chief Executive Officer | PPurchase | +6.78K | $0.74 | +$5.02K | +5.5%129.4K after | |
| Dec 19, 2022 (view filing) | Dec 16 | 3 days | Minai-Azary Jennifer LynnChief Financial Officer | PPurchase | +25.0K | $0.74 | +$18.5K | +166.7%40.0K after | |
| Dec 19, 2022 (view filing) | Dec 16 | 3 days | Lehr Martin A.Chief Executive Officer | PPurchase | +20.0K | $0.74 | +$14.8K | +19.5%122.6K after | |
| Dec 12, 2022 (view filing) | Dec 9 | 3 days | Levit Alex C.Chief Legal Officer, Corp. Sec | PPurchase | +6.00K | $0.85 | +$5.10K | +200.0%9.00K after | |
| Aug 22, 2022 (view filing) | Aug 19 | 3 days | Lehr Martin A.Chief Executive Officer | PPurchase | +13.0K | $1.85 | +$24.1K | +14.5%102.6K after | |
| Aug 17, 2022 (view filing) | Aug 17 | Same day | Minai-Azary Jennifer LynnChief Financial Officer | PPurchase | +15.0K | $1.80 | +$27.0K | New position15.0K after | |
| Aug 17, 2022 (view filing) | Aug 16 | 1 day | Sahmoud TarekChief Medical Officer | PPurchase | +10.0K | $1.95 | +$19.5K | New position10.0K after | |
| Dec 20, 2021 (view filing) | Dec 16 | 4 days | Lehr Martin A.Chief Executive Officer | PPurchase | +13.0K | $3.22 | +$41.9K | +1.6%820.2K after | |
| Dec 17, 2021 (view filing) | Oct 22 | 56 days | Lehr Martin A.Chief Executive Officer | PPurchase | +10.0K | $5.00 | +$50.0K | +1.3%807.2K after | Amended |
| Oct 25, 2021 (view filing) | Oct 22 | 3 days | Levit Alex C.Chief Legal Officer, Corp. Sec | PPurchase | +3.00K | $5.00 | +$15.0K | New position3.00K after |